Silva Ljevar
Impact in
-
- CAR-T cell therapy research
- COVID-19 and healthcare impacts
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Oncology 13
- CAR-T cell therapy research 6
- Inflammatory Biomarkers in Disease Prognosis 1
-
- Sarcoma Diagnosis and Treatment 1
- Prostate Cancer Treatment and Research 1
- Co-authors
- Paolo Corradini (8 shared papers)Rosalba Miceli (10 shared papers)Anna Guidetti (5 shared papers)Cristiana Carniti (4 shared papers)Martina Magni (4 shared papers)Daniele Morelli (2 shared papers)Paolo Verderio (3 shared papers)Giovanni Apolone (2 shared papers)
- Journals
- British Journal of Haematology (4 papers)Journal of Clinical Oncology (2 papers)Clinical Cancer Research (2 papers)Blood Advances (2 papers)European Journal of Cancer (1 paper)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Silva Ljevar
16 papers receiving 196 citations
Peers
Comparison fields: 5 of 34
- Oncology 117
- Infectious Diseases 38
- Immunology 29
- Cancer Research 18
- Pathology and Forensic Medicine 17
Countries citing papers authored by Silva Ljevar
This map shows the geographic impact of Silva Ljevar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silva Ljevar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silva Ljevar more than expected).
Fields of papers citing papers by Silva Ljevar
This network shows the impact of papers produced by Silva Ljevar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silva Ljevar. The network helps show where Silva Ljevar may publish in the future.
Co-authors
The 25 scholars most cited alongside Silva Ljevar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 55 | |
| 2 | 2022 | 39 | |
| 3 | 2022 | 25 | |
| 4 | 2022 | 21 | |
| 5 | 2023 | 12 | |
| 6 | 2024 | 9 | |
| 7 | 2022 | 7 | |
| 8 | 2023 | 6 | |
| 9 | 2022 | 5 | |
| 10 | 2024 | 4 | |
| 11 | 2024 | 4 | |
| 12 | 2023 | 3 | |
| 13 | 2024 | 2 | |
| 14 | 2023 | 2 | |
| 15 | 2025 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2023 | 0 |
About Silva Ljevar
Silva Ljevar is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine, having authored 17 papers that have together received 196 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Soft tissue tumor case studies (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Inflammatory Biomarkers in Disease Prognosis (1 paper), Prostate Cancer Treatment and Research (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (117 citations), Infectious Diseases (38 citations), Immunology (29 citations), Cancer Research (18 citations) and Pathology and Forensic Medicine (17 citations). Silva Ljevar has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Paolo Corradini, Rosalba Miceli, Anna Guidetti, Cristiana Carniti, Martina Magni, Daniele Morelli, Paolo Verderio, Giovanni Apolone, Annalisa Chiappella and Giuseppe Ippolito. Their work appears in journals such as British Journal of Haematology, Journal of Clinical Oncology, Clinical Cancer Research, Blood Advances and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.